Intrauterine growth restriction (IUGR), a condition that occurs due to various reasons, is an
important cause of fetal and neonatal morbidity and mortality. It has been defined as a rate of …

Intrauterine growth restriction (IUGR) continues to be a challenging problem for clinicians
despite advances in both obstetric and neonatal care. IUGR is defined as a rate of fetal …

Intrauterine growth restriction (IUGR) is a major and silent cause of various morbidity and
mortality for the fetal and neonatal population. It is defined as a rate of fetal growth that is …

Background: The reported prevalence of thyroid disease in pregnancy varies widely through
the published literature. These discrepancies are due to differences in criteria for …

Abstract Nafion byproduct 2 (NBP2) is a polyfluoroalkyl ether sulfonic acid that was recently
detected in surface water, drinking water, and human serum samples from monitoring …

Background: A number of phenols and parabens are added to consumer products for a
variety of functions, and have been found at detectable levels in the majority of the US …

Previous study reported that gestational Di-(2-ethylhexyl) phthalate (DEHP) exposure
caused fetal intrauterine growth restriction (IUGR). We aimed to investigate the role of …

Purpose To review the literature on thyroid function and thyroid disorders during pregnancy.
Methods A detailed literature research on MEDLINE, Cochrane library, EMBASE, NLH …

Background Phthalates, endocrine-disrupting chemicals that are commonly found in
consumer products, may adversely affect thyroid hormones, but findings from prior …

Isolated maternal hypothyroxinemia (IMH) during pregnancy is defined as a low maternal T
4 in the absence of TSH elevation. As IMH is common, with a prevalence of 1–2% in iodine …